A new breast cancer drug that could help increase survival rates has been approved.
Perjeta has been trialled at the Christie Hospital in Manchester.
Doctors found that, combined with other drugs and chemotherapy, it could extend the lives of thousands of patients.
Now it could be introduced across the country.
Elaine Willcox reports.